Drug profile · INN
spectinomycin hydrochloride
TROBICIN
spectinomycin hydrochloride (TROBICIN) is a bacterial 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — spectinomycin hydrochloride
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
spectinomycin hydrochloride (TROBICIN) is a bacterial 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Bacterial 70S ribosome inhibitor
Primary target: Bacterial 70S ribosome
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is spectinomycin hydrochloride?
spectinomycin hydrochloride (TROBICIN) is a bacterial 70s ribosome inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for spectinomycin hydrochloride?
TROBICIN is a marketed brand name for spectinomycin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of spectinomycin hydrochloride?
spectinomycin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.